FDA Approves Futibatinib for Certain Biliary Tract Cancers ...Middle East

The indication is for use in adult patients with previously treated intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements. FDA Approvals

Hence then, the article about fda approves futibatinib for certain biliary tract cancers was published today ( Monday 03/10/2022 - 05:28 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Futibatinib for Certain Biliary Tract Cancers )

Also on site :

• Advantech Unveils Next-Generation Edge AI Compute Solutions Powered by Qualcomm Dragonwing IQ-X Series
• From collapse fears to resilience: How Russia reshaped its economy by the end of 2025
• Russian MOD shows map of Ukrainian drone attack on Putin’s residence